Literature DB >> 27229905

An introduction to biomaterial-based strategies for curbing autoimmunity.

Jamal S Lewis1, Riley P Allen2.   

Abstract

Recently, scientists have made significant progress in the development of immunotherapeutics that correct aberrant, autoimmune responses. Yet, concerns about the safety, efficacy, and wide scale applicability continue to hinder use of contemporary, immunology-based strategies. There is a clear need for therapies that finely control molecular and cellular elements of the immune system. Biomaterial engineers have taken up this challenge to develop therapeutics with selective spatial and temporal control of immune cells. In this review, we introduce the immunology of autoimmune disorders, survey the current therapeutic strategies for autoimmune diseases, and highlight the ongoing research efforts to engineer the immune system using biomaterials, for positive therapeutic outcomes in treatment of autoimmune disorders.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Immuno-engineering; autoimmune disease; biomaterials; immunotherapy; particulate; tolerogenic

Mesh:

Substances:

Year:  2016        PMID: 27229905      PMCID: PMC4950372          DOI: 10.1177/1535370216650294

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  74 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Shape induced inhibition of phagocytosis of polymer particles.

Authors:  Julie A Champion; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-06-12       Impact factor: 4.200

Review 4.  Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards.

Authors:  Hafsa Munir; Helen M McGettrick
Journal:  Stem Cells Dev       Date:  2015-07-28       Impact factor: 3.272

Review 5.  Negative selection of lymphocytes.

Authors:  G J Nossal
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

6.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

7.  Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.

Authors:  Jamal S Lewis; Chris Roche; Ying Zhang; Todd M Brusko; Clive H Wasserfall; Mark Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

Review 8.  Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.

Authors:  Barbara E Ostrov
Journal:  Immunol Invest       Date:  2015       Impact factor: 3.657

9.  Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells.

Authors:  Mutsumi Yoshida; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2004-10-01       Impact factor: 4.396

10.  The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens.

Authors:  Ya-Wun Yang; Paul Yueh-Jen Hsu
Journal:  Biomaterials       Date:  2008-03-10       Impact factor: 12.479

View more
  6 in total

Review 1.  Dendritic cells in the host response to implanted materials.

Authors:  Benjamin G Keselowsky; Jamal S Lewis
Journal:  Semin Immunol       Date:  2017-05-07       Impact factor: 11.130

2.  Latent, Immunosuppressive Nature of Poly(lactic-co-glycolic acid) Microparticles.

Authors:  Riley P Allen; Amir Bolandparvaz; Jeffrey A Ma; Vishal A Manickam; Jamal S Lewis
Journal:  ACS Biomater Sci Eng       Date:  2018-02-03

Review 3.  Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis.

Authors:  Allen B Tu; Jamal S Lewis
Journal:  Drug Deliv Transl Res       Date:  2021-08-19       Impact factor: 4.617

4.  Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications.

Authors:  Noah Pacifici; Amir Bolandparvaz; Jamal S Lewis
Journal:  Adv Ther (Weinh)       Date:  2020-08-02

Review 5.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

Review 6.  Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.

Authors:  Charles J Kroger; Matthew Clark; Qi Ke; Roland M Tisch
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.